Replimune Group (REPL) 2025 Earnings Call Presentation

Investor Day June 24, 2025 Igniting a systemic immune response to cancer with oncolytic immunotherapy © 2025 Replimune Group Inc. Safe harbor Any statements contained herein that are not statements of historical facts may be deemed to be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding the advancement, timing and sufficiency of our clinical trials or finan ...